Scleroderma is a chronic autoimmune disease of women. Over time, people living with scleroderma develop progressive and irreversible scarring. Scarring, called fibrosis, affects the lungs, heart and kidneys, leading to poor quality of life, disability and a reduced life expectancy.
Antibody targeting CD38 enzyme shows positive impact in treating systemic sclerosis retrieved 6 September 2024 from https://medicalxpress.com/news/2024-09-antibody-cd38-enzyme-positive-impact.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Jan 31, 2023Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New antibody treatment shows promise in preventing heart transplant rejectionnA new study from scientists at Cincinnati Children's suggests there may be a way to further protect transplanted hearts from rejection by preparing the donor organ and the recipient with an anti-inflammatory antibody treatment before surgery occurs.
Read more »
New insights into antibody roles could improve malaria vaccines for childrenThe first malaria vaccine approved by the World Health Organization—known as RTS,S—was a big step forward in the fight against the disease. While the vaccine protects young children, it is moderate and wears off approximately 18 months after vaccination.
Read more »
Novel monoclonal antibody appears effective at neutralizing numerous SARS-CoV-2 variantsA monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.
Read more »
Monoclonal antibody tops placebo for reducing migraine frequencyThe humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, Lu AG09222, is better than placebo for reducing migraine frequency over four weeks, according to a study published in the Sept. 5 issue of the New England Journal of Medicine.
Read more »
Newly discovered antibody protects against all COVID-19 variantsResearchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly related SARS-like coronaviruses that infect other animals.
Read more »
Newly discovered antibody can neutralize all known variants of SARS-CoV-2Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly related SARS-like coronaviruses that infect other animals.
Read more »